Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene

被引:0
|
作者
Gaëlle Bougeard
Laurence Brugières
Agnès Chompret
Paul Gesta
Françoise Charbonnier
Alexander Valent
Cosette Martin
Grégory Raux
Jean Feunteun
Brigitte Bressac-de Paillerets
Thierry Frébourg
机构
[1] Inserm EMI 9906 – IFRMP,Department of Pediatrics
[2] Faculty of Medicine,Department of Genetics
[3] Institut Gustave Roussy,Department of Cellular Genomics of Cancers
[4] Oncology,Department of Clinical Biology
[5] Centre Hospitalier,undefined
[6] CHU of Rouen,undefined
[7] Institut Gustave Roussy,undefined
[8] UMR 8125,undefined
[9] Institut Gustave Roussy,undefined
[10] Institut Gustave Roussy,undefined
来源
Oncogene | 2003年 / 22卷
关键词
Li–Fraumeni syndrome; deletion; PCR;
D O I
暂无
中图分类号
学科分类号
摘要
The absence of detectable germline TP53 mutations in a fraction of families with Li–Fraumeni syndrome (LFS) has suggested the involvement of other genes, but this hypothesis remains controversial. The density of Alu repeats within the TP53 gene led us to search genomic rearrangements of TP53 in families without detectable TP53 mutation. To this aim, we adapted the quantitative multiplex PCR of short fluorescent fragments (QMPSF) method to the analysis of the 11 exons of TP53. We analysed 98 families, either fulfilling (six families) or partially meeting (92 families) the criteria for LFS, and in which classical methods had failed to reveal TP53 alterations. We identified, in a large family fulfilling the criteria for LFS, a complete heterozygous deletion of TP53. Additional QMPSF analyses indicated that this deletion, which partially removed the centromeric FLJ10385 locus, covered approximately 45 kb. This deletion was shown to result from a complex rearrangement involving two distinct Alu-mediated recombinations. We conclude that TP53 germline rearrangements occur as rare events, but must be considered in LFS families without detectable point TP53 mutation.
引用
收藏
页码:840 / 846
页数:6
相关论文
共 50 条
  • [1] Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene
    Bougeard, G
    Brugières, L
    Chompret, A
    Gesta, P
    Charbonnier, F
    Valent, A
    Martin, C
    Raux, G
    Feunteun, J
    Bressac-de Paillerets, B
    Frébourg, T
    ONCOGENE, 2003, 22 (06) : 840 - 846
  • [2] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [3] TP53 MUTATIONS AND LI-FRAUMENI SYNDROME
    Hainaut, P.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 703 - 703
  • [4] Detection of the first complete heterozygous deletion of the TP53 gene in a family with Li-Fraumeni syndrome.
    Bougeard, G
    Charbonnier, F
    Martin, C
    Raux, G
    Brugieres, L
    de Paillerets, BB
    Frebourg, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 232 - 232
  • [5] Germline TP53 mutations and Li-Fraumeni syndrome
    Varley, JM
    HUMAN MUTATION, 2003, 21 (03) : 313 - 320
  • [6] Inherited TP53 Mutations and the Li-Fraumeni Syndrome
    Guha, Tanya
    Malkin, David
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (04):
  • [7] A Novel Variant in the TP53 Gene Causing Li-Fraumeni Syndrome
    Papadimitriou, Dimitrios T.
    Stratakis, Constantine A.
    Kattamis, Antonis
    Glentis, Stavros
    Dimitrakakis, Constantine
    Spyridis, George P.
    Christopoulos, Panagiotis
    Mastorakos, George
    Vlahos, Nikolaos F.
    Iacovidou, Nicoletta
    CHILDREN-BASEL, 2023, 10 (07):
  • [8] Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome
    Jillian M Birch
    Valerie Blair
    Anna M Kelsey
    D Gareth Evans
    Martin Harris
    Karen J Tricker
    Jennifer M Varley
    Oncogene, 1998, 17 : 1061 - 1068
  • [9] TP53 or Not TP53: That Is the Question
    Green, Steven D.
    Zeidner, Joshua F.
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5235 - 5237
  • [10] A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome
    DockhornDwomiczak, B
    Wolff, J
    Poremba, C
    Schafer, KL
    Ritter, J
    Gullotta, F
    Jurgens, H
    Bocker, W
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1359 - 1365